| human | Q5 |
| P496 | ORCID iD | 0000-0003-2322-8203 |
| P108 | employer | Toranomon Hospital | Q11625273 |
| P106 | occupation | researcher | Q1650915 |
| Q39658631 | A clinical staging score to measure the severity of dialysis-related amyloidosis |
| Q40040838 | AA Amyloidosis and Atypical Familial Mediterranean Fever with Exon 2 and 3 Mutations |
| Q44995645 | Adalimumab treatment in patients with rheumatoid arthritis with renal insufficiency |
| Q37414389 | Bone Histology of Two Cases with Osteomalacia Related to Low-dose Adefovir |
| Q44847591 | Bone mineral density 5 years after parathyroidectomy in hemodialysis patients with secondary hyperparathyroidism |
| Q36106506 | CD1a+ survivin+ dendritic cell infiltration in dermal lesions of systemic sclerosis |
| Q38692193 | Cefepime-induced encephalopathy in end-stage renal disease patients. |
| Q42267414 | Characteristics of Intravascular Large B-Cell Lymphoma Limited to the Glomerular Capillaries: A Case Report |
| Q41971741 | Clinical and pathological evaluation of hypertensive emergency-related nephropathy |
| Q34454102 | Clinical course after corticosteroid therapy in IgG4-related aortitis/periaortitis and periarteritis: a retrospective multicenter study |
| Q43870516 | Clinical features of cyst infection and hemorrhage in ADPKD: new diagnostic criteria |
| Q39300878 | Current treatment status of polycystic liver disease in Japan |
| Q38061889 | Cushing's syndrome after hemodialysis for 21 years |
| Q30413995 | Developing an HbA(1c)-based equation to estimate blood glucose in maintenance hemodialysis patients |
| Q42948710 | Development of myeloperoxidase-antineutrophil cytoplasmic antibody-associated renal vasculitis in a patient receiving treatment with anti-tumor necrosis factor-α |
| Q35904061 | Effect of Proteinuria and Glomerular Filtration Rate on Renal Outcome in Patients with Biopsy-Proven Benign Nephrosclerosis |
| Q40040634 | Effect of renal transcatheter arterial embolization on quality of life in patients with autosomal dominant polycystic kidney disease |
| Q35573596 | Effects of percutaneous ethanol injection therapy on subsequent surgical parathyroidectomy |
| Q58776885 | Eltrombopag Improves Refractory Thrombocytopenia in a Patient with Systemic Lupus Erythematosus |
| Q44307704 | Emphysematous cyst infection in autosomal dominant polycystic kidney disease |
| Q31063518 | Estimation of the number of histological diagnosis for IgG4-related kidney disease referred to the data obtained from the Japan Renal Biopsy Registry (J-RBR) questionnaire and cases reported in the Japanese Society of Nephrology Meetings |
| Q33388583 | Etanercept-refractory adult-onset Still's disease with thrombotic thrombocytopenic purpura successfully treated with tocilizumab |
| Q26751411 | Evidence-based clinical practice guidelines for nephrotic syndrome 2014 |
| Q26752272 | Evidence-based clinical practice guidelines for polycystic kidney disease 2014 |
| Q37440665 | Factors related to renal cortical atrophy development after glucocorticoid therapy in IgG4-related kidney disease: a retrospective multicenter study. |
| Q37139961 | Familial Mediterranean fever is no longer a rare disease in Japan |
| Q37414378 | Five Sequential Evaluations of Renal Histology in a Patient with Light Chain Deposition Disease |
| Q38615734 | Hemodialysis without Anticoagulation for a Patient with Chronic Disseminated Intravascular Coagulation |
| Q40323484 | Hyperparathyroidism in a diabetic patient on dialysis |
| Q27324613 | Identification of MMP1 as a novel risk factor for intracranial aneurysms in ADPKD using iPSC models |
| Q33705977 | Internal Carotid Artery Occlusion in Systemic Lupus Erythematosus as a Potential Mimicker of Multiple Sclerosis. |
| Q36187889 | Intracystic magnetic resonance imaging in patients with autosomal dominant polycystic kidney disease: features of severe cyst infection in a case-control study |
| Q46211961 | Intravascular embolization therapy in patients with enlarged polycystic liver |
| Q33409230 | Long term follow up of congenital thrombotic thrombocytopenic purpura (Upshaw-Schulman syndrome) on hemodialysis for 19 years: a case report |
| Q33894748 | Long-term Low-density Lipoprotein Apheresis in a Patient with Refractory Idiopathic Membranous Glomerulonephritis |
| Q40350184 | Long-term preserved renal function of a patient with mass-forming granulomatous interstitial nephritis by biopsy-based steroid therapy |
| Q40135241 | Malignant nephrosclerosis in a patient with familial Mediterranean fever |
| Q33408092 | Membranoproliferative glomerulonephritis and circulating cryoglobulins |
| Q39123794 | Multicentric Castleman's disease associated with IgA vasculitis (Henoch-Schönlein purpura) responding well to tocilizumab: a case report. |
| Q40475300 | Mycosis fungoides in a hemodialysis patient with intractable pruritus. |
| Q34686938 | Myeloperoxidase-antineutrophil cytoplasmic antibody-associated crescentic glomerulonephritis in autosomal dominant polycystic kidney disease |
| Q38878457 | Nationwide multicentre kidney biopsy study of Japanese patients with type 2 diabetes. |
| Q41414935 | Paratubular basement membrane insudative lesions predict renal prognosis in patients with type 2 diabetes and biopsy-proven diabetic nephropathy. |
| Q34459201 | Peritoneal Dialysis is Limited by Kidney and Liver Volume in Autosomal Dominant Polycystic Kidney Disease |
| Q40621241 | Phospholipase A2 Receptor-Positive Idiopathic Membranous Glomerulonephritis with Onset at 95 Years: Case Report |
| Q35975767 | Primary effusion lymphoma-like lymphoma with polycystic kidney disease |
| Q36770851 | Prognostic Value of Tubulointerstitial Lesions, Urinary N-Acetyl-β-d-Glucosaminidase, and Urinary β2-Microglobulin in Patients with Type 2 Diabetes and Biopsy-Proven Diabetic Nephropathy |
| Q34974404 | Quality of life of patients with ADPKD-Toranomon PKD QOL study: cross-sectional study |
| Q36586844 | Recovery of renal function after glucocorticoid therapy for IgG4-related kidney disease with renal dysfunction |
| Q34525533 | Rectus sheath haematoma in a patient receiving haemodialysis |
| Q37414386 | Recurrent Cholangitis in a Patient with Autosomal Dominant Polycystic Kidney Disease (ADPKD) and Caroli's Disease |
| Q37464204 | Renal prognosis a long time after renal biopsy on patients with diabetic nephropathy |
| Q41885272 | Sjögren Syndrome-Related Membranous Glomerulonephritis Progressing to Membranoproliferative Glomerulonephritis |
| Q35682187 | Sleep-Disordered Breathing in Patients with Polycystic Liver and Kidney Disease Referred for Transcatheter Arterial Embolization |
| Q40474398 | Successful renal transcatheter arterial embolization in three patients with symptomatic hydronephrosis due to ureteral obstruction. |
| Q39973431 | Successful treatment of primary AL amyloidosis by VAD therapy, high-dose melphalan, and autologous peripheral stem cell transplantation |
| Q40172573 | Successful treatment with humanized anti-interleukin-6 receptor antibody (tocilizumab) in a case of AA amyloidosis complicated by familial Mediterranean fever |
| Q37051977 | Suitability of Patients with Autosomal Dominant Polycystic Kidney Disease for Renal Transcatheter Arterial Embolization |
| Q41735472 | Survival after arterial embolization therapy in patients with polycystic kidney and liver disease |
| Q40341645 | The renal cyst infection caused by Salmonella enteritidis in a patient with autosomal dominant polycystic kidney disease: how did this pathogen come into the renal cysts? |
| Q41051554 | Tocilizumab for AA Amyloidosis after Treatment of Multicentric Castleman Disease with Steroids, Chemotherapy and Rituximab for Over 20 Years |
| Q42368835 | Tolvaptan for the Treatment of Enlarged Polycystic Liver Disease. |
| Q43219976 | Transarterial renal embolization for enlarged horseshoe kidney |
| Q35155738 | Tumoral calcinosis in a patient with hypoparathyroidism, sensorineural deafness, and renal dysplasia syndrome undergoing hemodialysis |
| Q33427480 | Two Types of Renovascular Lesions in Lupus Nephritis with Clinical Thrombotic Thrombocytopenic Purpura |
| Q35103589 | Umbilical hernia in autosomal dominant polycystic kidney disease |
| Q40249413 | Unique hemoglobin A1c level distribution and its relationship with mortality in diabetic hemodialysis patients |
| Q40414828 | Ursodeoxycholic Acid for Treatment of Enlarged Polycystic Liver |
| Q37352182 | Using hemoglobin A1c to derive mean blood glucose in peritoneal dialysis patients |
| Q37332025 | Variegate porphyria complicated by systemic AA amyloidosis: a case report. |
Search more.